4//SEC Filing
Sachs David C. 4
Accession 0001326110-23-000115
CIK 0001326110other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 7:41 PM ET
Size
7.2 KB
Accession
0001326110-23-000115
Insider Transaction Report
Form 4
Sachs David C.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-09-01+70,744→ 122,042 total - Exercise/Conversion
Restricted Stock Units
2023-09-01−70,744→ 70,745 total→ Common Stock (70,744 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 70,744 of the shares subject to the RSU award vested on September 1, 2023 and 70,745 of the shares shall vest on January 31, 2024.
Documents
Issuer
ImmunityBio, Inc.
CIK 0001326110
Entity typeother
Related Parties
1- filerCIK 0001848899
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 7:41 PM ET
- Size
- 7.2 KB